Rasagiline Mesylate in Patients With Multiple System Atrophy of the Parkinsonian Subtype

Study Title

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Teva Identifier

MSA-RAS-202 | 2009-014644-11

ClinicalTrials.gov Identifier

NCT00977665

Study Status

Completed

Trial Condition(s)

Multiple System Atrophy

Interventions

Drug: rasagiline mesylate | Drug: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

30 Years and older

Trial Duration

12/01/2009 - 10/01/2011

Phase

Phase 2

Study Type

Interventional